Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, contr...
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
About this item
Full title
Author / Creator
Green, Ari J , Gelfand, Jeffrey M , Cree, Bruce A , Bevan, Carolyn , Boscardin, W John , Mei, Feng , Inman, Justin , Arnow, Sam , Devereux, Michael , Abounasr, Aya , Nobuta, Hiroko , Zhu, Alyssa , Friessen, Matt , Gerona, Roy , von Büdingen, Hans Christian , Henry, Roland G , Hauser, Stephen L and Chan, Jonah R
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Multiple sclerosis is a degenerative inflammatory disease of the CNS characterised by immune-mediated destruction of myelin and progressive neuroaxonal loss. Myelin in the CNS is a specialised extension of the oligodendrocyte plasma membrane and clemastine fumarate can stimulate differentiation of oligodendrocyte precursor cells in vitro, in animal...
Alternative Titles
Full title
Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1951416098
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1951416098
Other Identifiers
ISSN
0140-6736
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(17)32346-2
